Association between cognitive impairment and cerebrovascular disease

Slides:



Advertisements
Similar presentations
Vascular cognitive impairment – an overview
Advertisements

Significance of White Matter Hyperintensities in MCI Charles DeCarli University of California at Davis Alzheimer’s Disease Center Imaging of Dementia and.
Screening By building screening for symptoms of VCI into regular workflows or practice, health care providers are participating in Taking Action to address.
Subtype of VaD: SIVD Subcortical Ischemic Vascular Disease Helena Chui, M.D. University of Southern California Rancho Los Amigos National Rehabilitation.
Glucose Levels and Risk of Dementia Presented by - Anas Kabaha, MD Sheba medical center Sheba medical center August 8,2013.
Screening for Stroke and Cognitive Impairment Chapter 2: Background.
Health Disparities in Cardiovascular Disease Paula A. Johnson, MD, MPH Chief, Division of Women’s Health; Executive Director, Connors Center for Women’s.
Global impact of ischemic heart disease World Heart Federation, 2011.
20 Cardiovascular Disease and Physical Activity chapter.
Coronary Artery Disease  Coronary artery disease is one of the most common and serious effects of aging. Fatty deposits build up in blood vessel walls.
The Healthy Body, Healthy Brain Campaign Alaska Commission on Aging Alaska Division of Public Health Alaska Mental Health Trust Legislative Health Caucus.
ALZHEIMER’S PART 2. AD VIDEO
Mild Cognitive Impairment
«Blood stroke» Abdurashitov & Bezsonov. Stroke.What is? A stroke, or cerebrovascular accident (CVA), is the rapid loss of brain function(s) due to disturbance.
Grow Your Brain at Any Age Majid Fotuhi, MD PhD Howard County Office on Aging Columbia, MD March 28, 2014.
Six Steps to a Better Brain Majid Fotuhi, MD PhD March 6, 2014.
Primordial, primary, secondary, and tertiary prevention stages for global vascular risk. R. Sacco: Stroke, Volume 38(6).June
WHAT DO YOU REMEMBER ABOUT ALZHEIMER’S DEMENTIA?.
Alzheimer’s Disease  Goals  To understand what dementia is  To explore causes, risk factors, symptoms, and treatments of Alzheimer’s Disease  To better.
How To Grow Your Hippocampus in Three Months Majid Fotuhi, MD PhD Founder and Chief Medical Officer NeurExpand Brain Center Nothing to disclose.
Cardiovascular Diseases and ECG tracings Cardiologist for the day!
Is It Alzheimer’s? The Latest Update on Optimal Evaluation and Treatment of Patients with Memory Loss Majid Fotuhi, MD PhD March 5, 2014.
Epidemiology of Alzheimer’s Disease
Cerebrovascular function with aging and in Alzheimer’s disease Alzheimer’s disease, Aβ and vascular hypotheses. Assessment of cerebral autoregulation and.
Neurobiology of Dementia Majid Barekatain, M.D., Associate Professor of Psychiatry Neuropsychiatrist Isfahan University of Medical Sciences Ordibehesht.
2007 Hypertension as a Public Health Risk January, 2007.
Date of download: 5/29/2016 From: Statins and Cognitive Function: A Systematic Review Ann Intern Med. 2013;159(10): doi: /
Improvements needed in the care of people living with Dementia.
Global health in the news h/study-shows-spread-of-cigarettes-in- china.html?ref=health&_r=0.
The Predictability of Eye Disease for Alzheimer Disease 由眼睛疾病預測阿茲海默症 臺北市立聯合醫院 翁林仲 陳少鈞.
The Link Between Persistent Atrial Fibrillation and Dementia
Antonio Coca, MD, PhD, FRCP, FESC
Value of cerebrospinal fluid visinin-like protein-1 (VILIP-1) for prediction of mild cognitive impairment progression to Alzheimer's disease  Mirjana Babić.
José L Molinuevo, Craig Ritchie, Miia Kivipelto
In collaboration with:
Methodist LeBonheur Healthcare
DEMENTIA Shenae Whitfield & Kate Maddock.
Rosa Maria Moresco University of Milan Bicocca
World Health Organization
From: Statins and Cognitive FunctionA Systematic Review
Preventing Cardiovascular Disease
Preventing Cardiovascular Disease
The Health Benefits of Physical Activity
Hypertension Hanna K. Al-Makhamreh, MD FACC Interventional Cardiology.
What will it take to develop an effective Alzheimer’s drug?
Poststroke dementia Vikas Dhikav,
Imaging AD Progression Amyloid Imaging Agents.
Hazard ratio (HR) for mortality for a 1-kg/m2 increase in body mass index (BMI) across the range of baseline BMI among patients with acute ischemic stroke.
Cognitive Disorders and Aging
Mechanisms, Clinical Significance, and Prevention of Cognitive Impairment in Patients With Atrial Fibrillation  Lena Rivard, MD, MSc, Paul Khairy, MD,
Progress Report on Alzheimer’s Disease
Early Cognitive Decline and the Aging Brain - Overview
Early Dementia Distinguishing AD From MCI
Chapter 30 Delirium and Dementia
Reisa Sperling, Elizabeth Mormino, Keith Johnson  Neuron 
Prevalence of statin and beta-blocker use by clinical presentation
The Research Question Aim TIA is defined by short-lasting symptoms
José L Molinuevo, Craig Ritchie, Miia Kivipelto
Volume 352, Pages S15-S18 (October 1998)
The Cardiovascular Health Study:
I Can’t Find My Keys – Should I Be Worried?
Kotseva K, et al. Lancet 2009;373:929-40
Figure 2 A case of early-onset PSD
Pathology Of Hypertension
Diabetes, prediabetes, and cardiovascular risk: Shifting the paradigm
Fig. 1. AD biomarker levels in the cerebrospinal fluid of iNPH, AD, and CN subjects. Box plots of Aβ42 (A), Aβ40 (B), Aβ42/Aβ40 ratio (C), t-tau (D),
Alzheimer's Prevention Research and
Ongoing Research With Vascular Risk Factors and the RAS in Individuals at Risk for AD Whitney Wharton, PhD Assistant Professor,
in Younger and Older African Americans and Whites
Dementia in Africa: Focus on Nigeria
Presentation transcript:

Association between cognitive impairment and cerebrovascular disease Hege Ihle-Hansen MD, phd Vestre Viken HT, Bærum Hospital Norway

Outline Introduction Challenges Future directions Cognition Cerebrovascular disease Challenges Link between vascular disease and cognition Impact of vascular risk factors and treatment of vascular disease in older age Pathophysiology Future directions

What do we need to know Cardio vascular disease (CVD) and dementia shear many risk factors Many risk factors are modifiable Early identification and risk control may preserve cognitive function

Introduction

Neurocognitive disorders DSM-5 Ability to think Clinical diagnosis Contiuum Normal Mild neurocognitive disorder Major neuricognitive disorder Different subtypes or causes

Cerebrovascular disease

Atherosclerosis and cognition

Link between vascular disease and cognition Challenges Link between vascular disease and cognition

Dementia after stroke 10% av pasienter innlagt med første hjerneslag har demens før hjerneslag. 10% vil få demens som følge av hjerneslaget. Av alle innlagte slagpasienter vil ca 25% ha demens 1 år etter hjerneslaget. Høyest andel ved tilbakevendende hjerneslag. Videre ser man en gradvis økende prosentandel som utvikler demens. Post-stroke dementia (PSD) or post-stroke cognitive impairment (PSCI) Pendlebury, Int J Stroke, 2012

Cerebral White Matter Lesions and the Risk of Dementia Severity of white matter lesions (WML) is divided into 3 categories based on the distribution of periventricular WML scores. The risk of dementia is expressed as age- and sex-adjusted hazard ratios. The number of dementia cases and total number of participants, respectively, in consecutive periventricular WML severity categories were 16 and 749 (grade 0-3), 18 and 261 (grade >3-6), 11 and 66 (grade >6-9), and in consecutive subcortical WML severity categories 24 and 763 (0-1 mL), 10 and 244 (>1-6 mL), and 10 and 65 (>6-29.5 mL). Arch Neurol. 2004;61(10):1531-1534.

Kivipelto, Lancet Neurol 2006

Challenges Impact of vascular risk factors and treatment of vascular disease in older age

Risk factors for stroke High blood pressure  Cigarette smoking  Diabetes mellitus  Carotid or other artery disease  Atrial fibrillation  Other heart disease  High blood cholesterol  Poor diet  Physical inactivity and obesity  Stress

Source: Misfinancing global health: a case for transparency in disbursements and decision making. The Lancet D Sridhar, R Batniji 27 September 2008, 372: 9644, 1185 - 1191

Is it of clinical importance? Barnes, Lancet Neurol 2011

Challenges Pathophysiology

Vascular risk Vascular risk factors leads to angiopahty leading to cognitive decline macrovascular micro vascular Induce inflammation Interact with AD The vascular risk can directly increase the suscetibility to Alzheimer’s disease

Possible interactions between vascular and degenerative disease Loss of neurons Morbus Alzheimers Amyloid-β Cerebrovascular disease Ischemia Dementia ↑secretase activity ↓Aβ clearance Vascular Aβ deposit ↑tau phosphorylation Vasoconstriction

We aimed to explore the association between total-tau and brain atrophy, measured as ventricular volume and total brain volume, one year post-stroke

Future directions

Acute stroke treatment

Different trajectories Pet – amyloid avleiring 10 år før symptomer på kognitiv svikt Kartelgge alle slagpasienter med spinalpunkjson eller PET ? Inflammasjonen – vaskulære risikofakorer ? Gener? Mulige behmål – antiinflammatoriske legemidler ? Thiel et al Stroke. 2014;45:2825-2829

The Seven ways of life Be smart, exercise your heart: exercise effects on brain and cognition

Global targets for NCDs To be attained by 2025

Association between cognitive impairment and cerebrovascular disease Researsch Early diagnosis Prediction Prevention Treatment Risk factors Physical and cognitive training Succussfull aging? Expectations Multifactorial risk